Speaker illustration

Mr Sam Surette

Caption Health, Brisbane (United States of America)

Sam Surette is the Head of Regulatory Affairs and Quality Assurance at Caption Health. Sam obtained acceptance of the company's AI-guided imaging system into the U.S. Food & Drug Administration's (FDA) Breakthrough Devices Program, helped design the multi-center pivotal study to validate its clinical effectiveness, and lead the company to landmark De Novo FDA authorization. Prior to joining Caption Health, Sam spent four years as a reviewer at the FDA in the Division of Cardiovascular Devices, where he reviewed IDEs, 510(k)s, PMAs, and other submissions for cardiac electrophysiology devices, including the first FDA approval of a professional-use automated external defibrillator. He has a bachelor's degree in biomedical engineering from Washington University in St. Louis.

Artificial intelligence-guided image acquisition on patients with implanted electrophysiological devices: Results from a pivotal prospective multi-center clinical trial

Event: ESC Congress 2020

Topic: Technology

Session: Novel Technological Approaches in Echocardiography: What Do They Provide?


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb